Skip to Content

'
Janice A Blalock, Ph.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Janice A. Blalock, Ph.D. is a clinical psychologist with 19 years research experience in treatments for depression and anxiety disorders, and nicotine dependence. Her research area of interest is development of smoking cessation treatments for smokers with comorbid psychiatric and medical disorders. She was the Co-P.I. on a recently completed study evaluating a depression and smoking cessation intervention for pregnant smokers. She is currently conducting a NIMH-funded study evaluating the efficacy of a combined depression and smoking cessation intervention for smokers with chronic forms of depressive disorders who enter treatment with unremitted depressive episodes. Dr. Blalock also serves as the Assistant Director for the University of Texas M. D. Anderson Cancer Center’s Tobacco Treatment Program, which provides tobacco cessation services to all M.D. Anderson cancer patients. She has interest in evaluating smoking cessation treatments that are specifically tailored to meet the needs of cancer patients who have difficulty quitting following diagnosis and has several grant submissions under review that are focused on this topic; including a NCI funded study evaluating the efficacy of a novel smoking cessation intervention for cancer patients. She has published a number of articles evaluating the impact of clinical depression on withdrawal and abstinence outcomes among smokers with current depressive disorders, and the effect of psychiatric disorders on abstinence outcomes in cancer patients.   

Education & Training

Degree-Granting Education

1992 Virginia Polytechnic Institute & State University, Blacksburg, VA, PHD, Clinical Psychology
1991 Medical University of South Carolina, Charleston, SC, Internship, Psychology
1987 University of the Pacific, Stockton, CA, MA, Psychology
1980 Southwest Texas State University, San Marcos, TX, BS, Psychology

Selected Publications

Peer-Reviewed Original Research Articles
1. Blalock JA, Nayak N, Wetter DW, Schreindorfer L, Minnix JA, Canul J, Cinciripini PM. The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav 25(4):652-63, 12/2011. e-Pub 9/19/2011. PMID: 21928869.
2. Minnix JA, Blalock JA, Marani S, Prokhorov AV, Cinciripini PM. Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res 13(8):699-705, 8/2011. e-Pub 4/11/2011. PMCID: PMC3150689.
3. Blalock, JA, Lam, CY, Minnix, JA, Karam-Hage, M, Gritz, ER, Robinson, JD, Cinciripini, PM. The effect of mood, anxiety and alcohol use disorders on smoking cessation in cancer patients. Journal of Cognitive Psychotherapy 25(1):82-96, http://www.ingentaconnect.com/content/springer/jcogp/2011/00000025/00000001/art00008, 2/2011.
4. Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol 78(1):44-54, 2/2010. PMCID: PMC2881321.
5. Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet 40(1):49-58, 1/2010. e-Pub 10/2009. PMID: 19842028.
6. Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord 117(3):174-9, 10/2009. e-Pub 2/12/2009. PMID: 19217168.
7. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock JA, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer 115(19):4336-4344, 6/2009.
8. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav 22(1):122-128, 3/2008. PMID: 18298238.
9. Blalock JA, Fouladi RT, Cinciripini PM, Markowitz JC, Klein DN, Rothbaum BO, Arnow BA, Manber R, Riso LP, Sui D, McCullough JP, Jr. Cognitive and behavioral mediators of combined pharmacotherapy and psychotherapy of chronic depression. Cognitive Therapy and Research 32:197-211, 2008.
10. Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict 15(4):268-77, Jul-Aug, 7/2006. PMID: 16867921.
11. Mallen MJ, Blalock JA, Cinciripini PM. Using technology to serve patients and practitioners: a comprehensive tobacco-cessation program for cancer patients. Counseling and Psychotherapy Research 6(3):196-201, 2006.
12. Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addict Behav 30(6):1195-208, 7/2005. e-Pub 1/19/2005. PMID: 15925128.
13. Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 62(5):513-20, 5/2005. PMID: 15867104.
14. Santiago NJ, Klein DN, Vivian D, Arnow BA , Blalock JA, Kocsis JH, Markowitz JC, Manber R, Riso LP, Rothbaum BO, Rush AJ, Thase ME, McCullough, Jr JP, Keller MB. The therapeutic alliance and CBASP-specific skill acquisition in the treatment of chronic depression. Cognitive Therapy and Research 29(6):803-817, 2005.
15. Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, McCullough Jr JP, Rush AJ, Trivedi MH, Arnow BA, Dunner DL, Manber R, Rothbaum B, Thase ME, Keitner GI, Miller IW, Keller MB. Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. J Consult Clin Psychol 72(4):681-8, 8/2004. PMID: 15301653.
16. Vocisano C, Klein DN, Arnow BA, Rivera C, Blalock JA, Rothbaum B, Vivian D, Markowitz JC, Kocsis JH, Manber R, Castonguay L, Rush AJ, Borian FF, McCullough JP, Kornstein SG, Riso LP, Thase ME. Therapist variables that predict symptom change in psychotherapy with chronically depressed outpatients. Psychotherapy: Theory, Research, Practice, Training 41:255-265, 2004.
17. Klein DN, Schwartz JE, Santiago NJ, Vivian D, Vocisano C, Castonguay LG, Arnow B, Blalock JA, Manber R, Markowitz JC, Riso LP, Rothbaum B, McCullough JP, Thase ME, Borian FE, Miller IW, Keller MB. Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol 71(6):997-1006, 12/2003. PMID: 14622075.
18. Arnow BA, Manber R, Blasey C, Klein DN, Blalock JA, Markowitz JC, Rothbaum BO, Rush AJ, Thase ME, Riso LP, Vivian D, McCullough JP, Keller MB. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. J Consult Clin Psychol 71(6):1025-35, 12/2003. PMID: 14622078.
19. Manber R, Arnow B, Blasey C, Vivian D, McCullough JP, Blalock JA, Klein DN, Markowitz JC, Riso LP, Rothbaum B, Rush AJ, Thase ME, Keller MB. Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication. Psychol Med 33(4):693-702, 5/2003. PMID: 12785471.
20. Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG, Baile WF. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol 71(2):292-301, 4/2003. PMID: 12699023.
21. Keller MB, McCullough JP, Klein DN, et al. (Blalock, JA). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342:1462-1470, 2000.
22. Cinciripini PM, McClure JB, Wetter DW, Perry J, Blalock JA, Cinciripini LG, Friedman KE, Skaar K. An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tob Control 9 Suppl 3:III61-3, 2000. PMCID: PMC1766306.
23. Blalock JA, Joiner TE, Jr. Interaction of cognitive avoidance coping and stress in predicting depression and anxiety: Gender differences. Cognitive Therapy and Research 24:47-65, 2000.

Book Chapters
1. Coyne JC, Joiner TE Jr, Blalock JA. On the interpersonal nature of depression: Overview and synthesis. In: Interactional nature of depression: Advances in interpersonal approaches. American Psychological Association: Washington DC, 3-19, 1999.

Manuals, Teaching Aids, Other Teaching Publications
1. Glenwater AM, Blalock JA, Goepfert, H, Cinciripini P. Rehabilitation and quality of life. Ed(s) Goepfert H, et al.

Grant & Contract Support

Title: Sub Contract to: Neurobehavioral metrics for the assessment and treatment of depression
Funding Source: NIH/NIMH
Role: Co-Investigator
Principal Investigator: Chiu
Duration: 4/1/2010 - 3/31/2015
 
Title: Enhanced tobacco cessation program for university students
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Alex Prokhorov
Duration: 9/30/2009 - 8/31/2012
 
Title: Preliminary Effectiveness and Safety of Bupropion to Promote Smoking Cessation During Pregnancy
Funding Source: The Center for Clinical and Translational Sciences (CCTS)
Role: Co-Investigator
Principal Investigator: Paul Cinciripini
Duration: 9/1/2009 - 8/31/2011
 
Title: Intensive Smoking Cessation Intervention for Head and Neck Cancer Patients
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 7/1/2009 - 7/31/2013
 
Title: Optimizing the Delivery of Lifestyle Interventions in Cancer Survivors
Funding Source: MDACC-MRP
Role: Project 3 Leader: Concurrent vs. sequential smoking and physical activity intervention for cancer survivors
Duration: 5/1/2009 - 4/30/2012
 
Title: Administrative Supplement to: Smoking cessation intervention for depressed smokers: Treatment development; entitled Relationship of emotional reactivity to abstinence outcomes in smokers with current chronic depressive disorders
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 8/1/2008 - 2/28/2011
 
Title: Smoking cessation intervention for depressed smokers: Treatment development
Funding Source: NIMH
Role: Principal Investigator
Duration: 9/12/2006 - 2/28/2011
 
Title: A mood management intervention for pregnant smokers
Funding Source: NIDA
Role: Co-Principal Investigator
Duration: 8/1/2003 - 7/31/2009
 
Title: Developmental Project to 1 P50 CA91846: A study to evaluate the combination of scheduled smoking and Bupropion SR versus Bupropion SR alone for smoking cessation in bladder cancer patients
Funding Source: NCI
Role: Principal Investigator
Duration: 8/1/2002 - 7/31/2004
 
Title: Sub Contract to: Pre-surgical smoking cessation intervention in cancer
Funding Source: NIDA
Role: Co-Investigator
Principal Investigator: Cinciripini
Duration: 3/1/2002 - 2/28/2006
 
Title: A pilot study to evaluate a mood management smoking cessation intervention in depressed smokers
Funding Source: The University of Texas M.D. Anderson Cancer Center
Role: Principal Investigator
Duration: 10/1/2001 - 9/30/2003
 
Title: Scheduled smoking with transdermal nicotine
Funding Source: NIDA
Role: Co-Investigator
Principal Investigator: Cinciripini
Duration: 4/1/1998 - 3/31/2004

Last updated: 3/7/2013